Asthma Inhaler Device Market: Information by Type (Metered Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers), Mode of Operation (Manually Operated Inhaler Devices, Digitally-Operated Inhaler Devices), End User (Hospitals & Clinics, Homecare) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2027
ID: MRFR/MED/1122-CR | February 2021 | Region: Global | 124 Pages
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY 16
2.2 RESEARCH OBJECTIVE 16
2.3 LIST OF ASSUMPTIONS 16
3 RESEARCH METHODOLOGY
4 MARKET DYNAMICS
4.1 OVERVIEW 26
4.2 DRIVERS 27
4.2.1 RISING PREVALENCE OF ASTHMA 27
4.2.2 GROWING NEED FOR RESCUE MEDICATION 27
4.2.3 RISING DEMAND FOR METERED DOSE INHALERS 27
4.3 RESTRAINTS 29
4.3.1 TECHNICAL PROBLEMS WITH INHALER DEVICES 29
4.3.2 SIDE EFFECTS AND COMPLICATIONS DURING INHALATION 29
4.4 OPPORTUNITIES 30
4.4.1 ADVANCEMENT IN INHALER DEVICES 30
4.4.2 INCREASING DEMAND IN DEVELOPING COUNTRIES 30
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 31
5.1.1 BARGAINING POWER OF SUPPLIERS 32
5.1.2 BARGAINING POWER OF BUYERS 32
5.1.3 THREAT OF NEW ENTRANTS 32
5.1.4 THREAT OF SUBSTITUTES 32
5.1.5 INTENSITY OF RIVALRY 32
5.2 VALUE CHAIN ANALYSIS 33
5.2.1 R&D AND DESIGNING 34
5.2.2 MANUFACTURING 34
5.2.3 DISTRIBUTION 34
5.2.4 MARKETING AND SALES 34
5.2.5 POST-SALES MONITORING 34
6 ASTHMA INHALER DEVICE MARKET, BY TYPE
6.1 OVERVIEW 35
6.2 METERED DOSE INHALERS 37
6.3 DRY POWDER INHALERS 38
6.4 SOFT MIST INHALERS 39
7 ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
7.1 OVERVIEW 40
7.2 MANUALLY OPERATED INHALER DEVICES 41
7.3 DIGITALLY OPERATED INHALER DEVICES 42
8 ASTHMA INHALER DEVICE MARKET, BY END USER
8.1 OVERVIEW 43
8.2 HOSPITALS AND CLINICS 44
8.3 HOMECARE 45
8.4 OTHERS 45
9 GLOBAL ASTHMA INHALER DEVICE MARKET, BY REGION
9.1 OVERVIEW 46
9.2 AMERICAS 47
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.2.1 NORTH AMERICA 50
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.2.1.1 US 52
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.2.1.2 CANADA 53
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.2.2 LATIN AMERICA 54
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.3 EUROPE 56
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.3.1 WESTERN EUROPE 58
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.3.1.1 UK 60
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.3.1.2 GERMANY 61
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.3.1.3 FRANCE 63
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.3.1.4 ITALY 64
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.3.1.5 SPAIN 65
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.3.1.6 REST OF WESTERN EUROPE 67
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.3.2 EASTERN EUROPE 68
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.4 ASIA-PACIFIC 70
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.4.1.1 JAPAN 72
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.4.1.2 CHINA 73
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.4.1.3 INDIA 75
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.4.1.4 AUSTRALIA 76
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.4.1.5 SOUTH KOREA 77
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.4.1.6 REST OF ASIA-PACIFIC 79
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.5 MIDDLE EAST & AFRICA 81
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.5.1 MIDDLE EAST 83
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
9.5.2 AFRICA 85
ASTHMA INHALER DEVICE MARKET, BY TYPE
ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION
ASTHMA INHALER DEVICE MARKET, BY END USER
10 COMPETITIVE LANDSCAPE: GLOBAL ASTHMA INHALER DEVICE MARKET
10.1 OVERVIEW 87
10.2 COMPETITIVE ANALYSIS 87
10.3 COMPETITOR DASHBOARD 88
10.4 COMPETITIVE BENCHMARKING 89
10.5 MAJOR GROWTH STRATEGY IN THE GLOBAL ASTHMA INHALER DEVICE MARKET 90
10.6 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 90
10.7 KEY DEVELOPMENTS AND GROWTH STRATEGIES 91
10.7.1 COLLABORATION 91
10.7.2 ACQUISITION 92
10.7.3 PRODUCT APPROVAL AND LAUNCH 92
10.7.4 EXPANSION 93
10.8 MAJOR PLAYERS FINANCIAL MATRIX & MARKET RATIO 93
10.8.1 SALES & OPERATING INCOME 93
10.8.2 R&D EXPENDITURE 94
11 COMPANY PROFILE
11.1 GLAXOSMITHKLINE PLC 95
11.1.1 COMPANY OVERVIEW 95
11.1.2 FINANCIAL OVERVIEW 95
11.1.3 PRODUCTS/SERVICES OFFERED 96
11.1.4 KEY DEVELOPMENTS 96
11.1.5 SWOT ANALYSIS 97
11.1.6 KEY STRATEGIES 97
11.2 KONINKLIJKE PHILIPS NV 98
11.2.1 COMPANY OVERVIEW 98
11.2.2 FINANCIAL OVERVIEW 98
11.2.3 PRODUCTS/SERVICES OFFERED 99
11.2.4 KEY DEVELOPMENTS 99
11.2.5 SWOT ANALYSIS 99
11.2.6 KEY STRATEGIES 100
11.3 ASTRAZENECA 101
11.3.1 COMPANY OVERVIEW 101
11.3.2 FINANCIAL OVERVIEW 101
11.3.3 PRODUCTS/SERVICES OFFERED 102
11.3.4 KEY DEVELOPMENTS 102
11.3.5 SWOT ANALYSIS 103
11.3.6 KEY STRATEGIES 103
11.4 CIPLA INC. 104
11.4.1 COMPANY OVERVIEW 104
11.4.2 FINANCIAL OVERVIEW 104
11.4.3 PRODUCTS/SERVICES OFFERED 105
11.4.4 KEY DEVELOPMENTS 105
11.4.5 SWOT ANALYSIS 105
11.4.6 KEY STRATEGIES 106
11.5 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 107
11.5.1 COMPANY OVERVIEW 107
11.5.2 FINANCIAL OVERVIEW 107
11.5.3 PRODUCTS/SERVICES OFFERED 108
11.5.4 KEY DEVELOPMENTS 108
11.5.5 SWOT ANALYSIS 109
11.5.6 KEY STRATEGIES 109
11.6 BEXIMCO PHARMACEUTICALS LTD 110
11.6.1 COMPANY OVERVIEW 110
11.6.2 FINANCIAL OVERVIEW 110
11.6.3 PRODUCTS/SERVICES OFFERED 111
11.6.4 KEY DEVELOPMENTS 111
11.6.5 SWOT ANALYSIS 111
11.6.6 KEY STRATEGIES 112
11.7 MERCK & CO., INC. 113
11.7.1 COMPANY OVERVIEW 113
11.7.2 FINANCIAL OVERVIEW 113
11.7.3 PRODUCTS/SERVICES OFFERED 114
11.7.4 KEY DEVELOPMENTS 114
11.7.5 SWOT ANALYSIS 114
11.7.6 KEY STRATEGIES 114
11.8 TEVA PHARMACEUTICAL INDUSTRIES LTD 115
11.8.1 COMPANY OVERVIEW 115
11.8.2 FINANCIAL OVERVIEW 115
11.8.3 PRODUCTS/SERVICES OFFERED 116
11.8.4 KEY DEVELOPMENTS 116
11.8.5 SWOT ANALYSIS 117
11.8.6 KEY STRATEGIES 117
11.9 CHIESI FARMACEUTICI SPA 118
11.9.1 COMPANY OVERVIEW 118
11.9.2 FINANCIAL OVERVIEW 118
11.9.3 PRODUCTS/SERVICES OFFERED 119
11.9.4 KEY DEVELOPMENTS 119
11.9.5 SWOT ANALYSIS 119
11.9.6 KEY STRATEGIES 120
11.10 MEDISOL LIFESCIENCE PVT. LTD 121
11.10.1 COMPANY OVERVIEW 121
11.10.2 FINANCIAL OVERVIEW 121
11.10.3 PRODUCTS/SERVICES OFFERED 121
11.10.4 KEY DEVELOPMENTS 121
11.10.5 SWOT ANALYSIS 122
11.10.6 KEY STRATEGIES 122
12 APPENDIX
12.1 REFERENCES 123
12.2 RELATED REPORTS 123
13 LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS 16
TABLE 2 GLOBAL ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 36
TABLE 3 GLOBAL ASTHMA INHALER DEVICE MARKET FOR METERED DOSE INHALERS, BY REGION, 2020-2027 (USD MILLION) 37
TABLE 4 GLOBAL ASTHMA INHALER DEVICE MARKET FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 38
TABLE 5 GLOBAL ASTHMA INHALER DEVICE MARKET FOR DRY POWDER INHALERS, BY REGION, 2020-2027 (USD MILLION) 38
TABLE 6 GLOBAL ASTHMA INHALER DEVICE MARKET FOR SOFT MIST INHALERS, BY REGION, 2020-2027 (USD MILLION) 39
TABLE 7 GLOBAL ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 41
TABLE 8 GLOBAL ASTHMA INHALER DEVICE MARKET FOR MANUALLY OPERATED INHALER DEVICES, BY REGION,
2020-2027 (USD MILLION) 41
TABLE 9 GLOBAL ASTHMA INHALER DEVICE MARKET FOR DIGITALLY OPERATED INHALER DEVICES, BY REGION,
2020-2027 (USD MILLION) 42
TABLE 10 GLOBAL ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 44
TABLE 11 GLOBAL ASTHMA INHALER DEVICE MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020-2027 (USD MILLION) 44
TABLE 12 GLOBAL ASTHMA INHALER DEVICE MARKET FOR HOMECARE, BY REGION, 2020-2027 (USD MILLION) 45
TABLE 13 GLOBAL ASTHMA INHALER DEVICE MARKET, BY REGION, 2020-2027 (USD MILLION) 47
TABLE 14 AMERICAS: ASTHMA INHALER DEVICE MARKET, BY REGION, 2020-2027 (USD MILLION) 48
TABLE 15 AMERICAS: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 48
TABLE 16 AMERICAS: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 48
TABLE 17 AMERICAS: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 49
TABLE 18 AMERICAS: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 49
TABLE 19 NORTH AMERICA: ASTHMA INHALER DEVICE MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 50
TABLE 20 NORTH AMERICA: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 50
TABLE 21 NORTH AMERICA: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 51
TABLE 22 NORTH AMERICA: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 51
TABLE 23 NORTH AMERICA: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 51
TABLE 24 US: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 52
TABLE 25 US: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 52
TABLE 26 US: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 52
TABLE 27 US: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 53
TABLE 28 CANADA: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 53
TABLE 29 CANADA: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 53
TABLE 30 CANADA: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 54
TABLE 31 CANADA: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 54
TABLE 32 LATIN AMERICA: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 54
TABLE 33 LATIN AMERICA: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 55
TABLE 34 LATIN AMERICA: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 55
TABLE 35 LATIN AMERICA: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 55
TABLE 36 EUROPE: ASTHMA INHALER DEVICE MARKET, BY REGION, 2020-2027 (USD MILLION) 56
TABLE 37 EUROPE: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 57
TABLE 38 EUROPE: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 57
TABLE 39 EUROPE: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 57
TABLE 40 EUROPE: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 58
TABLE 41 WESTERN EUROPE: ASTHMA INHALER DEVICE MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 58
TABLE 42 WESTERN EUROPE: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 59
TABLE 43 WESTERN EUROPE: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 59
TABLE 44 WESTERN EUROPE: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 59
TABLE 45 WESTERN EUROPE: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 60
TABLE 46 UK: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 60
TABLE 47 UK: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 60
TABLE 48 UK: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 61
TABLE 49 UK: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 61
TABLE 50 GERMANY: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 61
TABLE 51 GERMANY: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 62
TABLE 52 GERMANY: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 62
TABLE 53 GERMANY: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 62
TABLE 54 FRANCE: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 63
TABLE 55 FRANCE: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 63
TABLE 56 FRANCE: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 63
TABLE 57 FRANCE: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 64
TABLE 58 ITALY: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 64
TABLE 59 ITALY: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 64
TABLE 60 ITALY: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 65
TABLE 61 ITALY: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 65
TABLE 62 SPAIN: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 65
TABLE 63 SPAIN: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 66
TABLE 64 SPAIN: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 66
TABLE 65 SPAIN: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 66
TABLE 66 REST OF WESTERN EUROPE: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 67
TABLE 67 REST OF WESTERN EUROPE: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE,
2020-2027 (USD MILLION) 67
TABLE 68 REST OF WESTERN EUROPE: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 67
TABLE 69 REST OF WESTERN EUROPE: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 68
TABLE 70 EASTERN EUROPE: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 68
TABLE 71 EASTERN EUROPE: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 68
TABLE 72 EASTERN EUROPE: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 69
TABLE 73 EASTERN EUROPE: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 69
TABLE 74 ASIA-PACIFIC: ASTHMA INHALER DEVICE MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 70
TABLE 75 ASIA-PACIFIC: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 71
TABLE 76 ASIA-PACIFIC: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 71
TABLE 77 ASIA-PACIFIC: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 71
TABLE 78 ASIA-PACIFIC: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 72
TABLE 79 JAPAN: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 72
TABLE 80 JAPAN: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 72
TABLE 81 JAPAN: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 73
TABLE 82 JAPAN: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 73
TABLE 83 CHINA: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 73
TABLE 84 CHINA: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 74
TABLE 85 CHINA: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 74
TABLE 86 CHINA: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 74
TABLE 87 INDIA: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 75
TABLE 88 INDIA: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 75
TABLE 89 INDIA: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 75
TABLE 90 INDIA: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 76
TABLE 91 AUSTRALIA: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 76
TABLE 92 AUSTRALIA: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 76
TABLE 93 AUSTRALIA: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 77
TABLE 94 AUSTRALIA: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 77
TABLE 95 SOUTH KOREA: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 77
TABLE 96 SOUTH KOREA: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 78
TABLE 97 SOUTH KOREA: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 78
TABLE 98 SOUTH KOREA: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 78
TABLE 99 REST OF ASIA-PACIFIC: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 79
TABLE 100 REST OF ASIA-PACIFIC: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 79
TABLE 101 REST OF ASIA-PACIFIC: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 79
TABLE 102 REST OF ASIA-PACIFIC: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 80
TABLE 103 MIDDLE EAST & AFRICA: ASTHMA INHALER DEVICE MARKET, BY REGION, 2020-2027 (USD MILLION) 81
TABLE 104 MIDDLE EAST & AFRICA: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 82
TABLE 105 MIDDLE EAST & AFRICA: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE,
2020-2027 (USD MILLION) 82
TABLE 106 MIDDLE EAST & AFRICA: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 82
TABLE 107 MIDDLE EAST & AFRICA: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 83
TABLE 108 MIDDLE EAST: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 83
TABLE 109 MIDDLE EAST: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 83
TABLE 110 MIDDLE EAST: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 84
TABLE 111 MIDDLE EAST: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 84
TABLE 112 AFRICA: ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION) 85
TABLE 113 AFRICA: ASTHMA INHALER DEVICE MARKET, FOR METERED DOSE INHALERS, BY TYPE, 2020-2027 (USD MILLION) 85
TABLE 114 AFRICA: ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020-2027 (USD MILLION) 85
TABLE 115 AFRICA: ASTHMA INHALER DEVICE MARKET, BY END USER, 2020-2027 (USD MILLION) 86
TABLE 116 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE ASTHMA INHALER DEVICE MARKET 90
TABLE 117 COLLABORATION: GLOBAL ASTHMA INHALER DEVICE MARKET 91
TABLE 118 ACQUISITION: GLOBAL ASTHMA INHALER DEVICE MARKET 92
TABLE 119 PRODUCT APPROVAL AND LAUNCH: GLOBAL ASTHMA INHALER DEVICE MARKET 92
TABLE 120 EXPANSION: GLOBAL ASTHMA INHALER DEVICE MARKET 93
TABLE 121 MAJOR PLAYERS R&D EXPENDITURE, 2020 94
TABLE 122 GLAXOSMITHKLINE PLC: PRODUCTS/SERVICES OFFERED 96
TABLE 123 GLAXOSMITHKLINE PLC: KEY DEVELOPMENTS 96
TABLE 124 KONINKLIJKE PHILIPS NV: PRODUCTS/SERVICES OFFERED 99
TABLE 125 KONINKLIJKE PHILIPS NV: KEY DEVELOPMENTS 99
TABLE 126 ASTRAZENECA: PRODUCTS/SERVICES OFFERED 102
TABLE 127 ASTRAZENECA: KEY DEVELOPMENTS 102
TABLE 128 CIPLA INC.: PRODUCTS/SERVICES OFFERED 105
TABLE 129 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS/SERVICES OFFERED 108
TABLE 130 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: KEY DEVELOPMENTS 108
TABLE 131 BEXIMCO PHARMACEUTICALS LTD: PRODUCTS/SERVICES OFFERED 111
TABLE 132 MERCK & CO., INC.: PRODUCTS/SERVICES OFFERED 114
TABLE 133 TEVA PHARMACEUTICAL INDUSTRIES LTD: FINANCIAL OVERVIEW SNAPSHOT 115
TABLE 134 TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCTS/SERVICES OFFERED 116
TABLE 135 TEVA PHARMACEUTICAL INDUSTRIES LTD: KEY DEVELOPMENTS 116
TABLE 136 CHIESI FARMACEUTICI SPA: PRODUCTS/SERVICES OFFERED 119
TABLE 137 CHIESI FARMACEUTICI SPA: KEY DEVELOPMENTS 119
TABLE 138 MEDISOL LIFESCIENCE PVT. LTD: PRODUCTS/SERVICES OFFERED 121
14 LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS 15
FIGURE 2 GLOBAL ASTHMA INHALER DEVICE MARKET: STRUCTURE 17
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 23
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF GLOBAL ASTHMA INHALER DEVICE MARKET 26
FIGURE 5 DRIVER IMPACT ANALYSIS 28
FIGURE 6 RESTRAINT IMPACT ANALYSIS 29
FIGURE 7 PORTER’S FIVE FORCES ANALYSIS: GLOBAL ASTHMA INHALER DEVICE MARKET 31
FIGURE 8 VALUE CHAIN ANALYSIS OF THE GLOBAL ASTHMA INHALER DEVICE MARKET 33
FIGURE 9 GLOBAL ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020 (%) 35
FIGURE 10 GLOBAL ASTHMA INHALER DEVICE MARKET, BY TYPE, 2020 & 2027 (USD MILLION) 36
FIGURE 11 GLOBAL ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020 (%) 40
FIGURE 12 GLOBAL ASTHMA INHALER DEVICE MARKET, BY MODE OF OPERATION, 2020 & 2027 (USD MILLION) 40
FIGURE 13 GLOBAL ASTHMA INHALER DEVICE MARKET, BY END USER, 2020 (%) 43
FIGURE 14 GLOBAL ASTHMA INHALER DEVICE MARKET, BY END USER, 2020 & 2027 (USD MILLION) 43
FIGURE 15 GLOBAL ASTHMA INHALER DEVICE MARKET, BY REGION, 2020 (%) 46
FIGURE 16 GLOBAL ASTHMA INHALER DEVICE MARKET, BY REGION, 2020 & 2027 (USD MILLION) 46
FIGURE 17 AMERICAS: ASTHMA INHALER DEVICE MARKET, BY REGION, 2020 (%) 47
FIGURE 18 NORTH AMERICA: ASTHMA INHALER DEVICE MARKET SHARE, BY COUNTRY, 2020 (%) 50
FIGURE 19 EUROPE: ASTHMA INHALER DEVICE MARKET, BY REGION, 2020 (%) 56
FIGURE 20 WESTERN EUROPE: ASTHMA INHALER DEVICE MARKET SHARE, BY COUNTRY, 2020 (%) 58
FIGURE 21 ASIA-PACIFIC: ASTHMA INHALER DEVICE MARKET SHARE, BY COUNTRY, 2020 (%) 70
FIGURE 22 MIDDLE EAST & AFRICA: ASTHMA INHALER DEVICE MARKET, BY REGION, 2020 (%) 81
FIGURE 23 COMPETITOR DASHBOARD: GLOBAL ASTHMA INHALER DEVICE MARKET 88
FIGURE 24 BENCHMARKING OF MAJOR COMPETITORS 89
FIGURE 26 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ASTHMA INHALER DEVICE MARKET 90
FIGURE 27 ASTHMA INHALER DEVICE MARKET, COMPETITIVE LANDSCAPE (% SHARE) 91
FIGURE 28 SALES & OPERATING INCOME, 2020 93
FIGURE 29 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW 95
FIGURE 30 GLAXOSMITHKLINE PLC: SWOT ANALYSIS 97
FIGURE 31 KONINKLIJKE PHILIPS NV: FINANCIAL OVERVIEW SNAPSHOT 98
FIGURE 32 KONINKLIJKE PHILIPS NV: SWOT ANALYSIS 99
FIGURE 33 ASTRAZENECA: FINANCIAL OVERVIEW SNAPSHOT 101
FIGURE 34 ASTRAZENECA: SWOT ANALYSIS 103
FIGURE 35 CIPLA INC: FINANCIAL OVERVIEW SNAPSHOT 104
FIGURE 36 CIPLA INC.: SWOT ANALYSIS 105
FIGURE 37 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: FINANCIAL OVERVIEW SNAPSHOT 107
FIGURE 38 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: SWOT ANALYSIS 109
FIGURE 39 BEXIMCO PHARMACEUTICALS LTD: FINANCIAL OVERVIEW SNAPSHOT 110
FIGURE 40 BEXIMCO PHARMACEUTICALS LTD: SWOT ANALYSIS 111
FIGURE 41 MERCK & CO., INC.: FINANCIAL OVERVIEW SNAPSHOT 113
FIGURE 42 MERCK & CO., INC.: SWOT ANALYSIS 114
FIGURE 43 TEVA PHARMACEUTICAL INDUSTRIES LTD: SWOT ANALYSIS 117
FIGURE 44 CHIESI FARMACEUTICI SPA: FINANCIAL OVERVIEW 118
FIGURE 45 CHIESI FARMACEUTICI SPA: SWOT ANALYSIS 119
FIGURE 46 MEDISOL LIFESCIENCE PVT. LTD: SWOT ANALYSIS 122
Asthma Inhaler Device Market
The Asthma Inhaler Device Market is expected to grow at a CAGR of 6.42% during the forecast period. The market is also expected to reach a revenue of USD 19.677.54 million by the end of 2020-2030.
$19.677.54 million
Market Size
6.42%
CAGR
North America
Dominating Region
2022-2030
Forecast Period
Segmentation
Key Players
- GlaxoSmithKline plc (UK)
- Koninklijke Philips NV (Netherlands)
- AstraZeneca (UK)
- Cipla Inc. (India)
- Boehringer Ingelheim International GmbH (Germany)
- Beximco Pharmaceuticals Ltd (Bangladesh)
- Merck & Co. Inc. (the US)
- Teva Pharmaceutical Industries Ltd (Israel)
- Chiesi Farmaceutici SpA (Italy)
- Medisol Lifescience Pvt. Ltd (India).
Drivers
- High prevalence of asthma
- Growing need for rescue medication
- Rising demand for metered-dose inhalers
Asthma Inhaler Device Market Overview
Based on the research, the Asthma Inhaler Device Market is expected to grow at a CAGR of 6.42% during the forecast period. The market is also expected to reach a revenue of USD 19.677.54 million by the end of 2020-2030.
Asthma, the chronic lung disease, is responsible for narrowing down and inflaming the airways. Problems like coughing, sneezing, tightness in the chest, difficulty breathing and shortness of breath are associated with asthma. asthma inhaler assistance devices are hand-held machines to treat such breathing problems. These machines are mainly used to treat or prevent diseases associated with the airways.
This report covers all the driving factor proving boost to the market growth. It also highlights many prominent key players of the market and what strategies they are adopting in order to sustain the high level of competition of the Asthma Inhaler Device Market. Post covid-19 scenario of the market and the market segmentations along with its regional analysis have been covered in the report.
Covid-19 impact
Although covid-19 has impacted most of the industries negatively, but it has also positive impact on some the few industries. Asthma Inhaler Device Market is one of such industries. A high amount of population was already suffering from asthma and covid-19 had made the situation even worse. As breathing problem is considered as one of the major symptoms of covid-19, it only increased the number of people suffering from breathing trouble.
Market dynamics
Drivers
Asthma Inhaler Device Market is expected to grow during the forecast period due to the rising cases of asthma. The prevalence of asthma in children and rising awareness among people are also increasing the demand for metered dose inhalers. This demands and rising awareness of asthma among people are driving the growth of the market.
Opportunities
Many prominent key players investing in research and development along with new product launches and collaborating with other players of the market are going to create a huge number of opportunities in the Asthma Inhaler Device Market.
Cumulative growth
In 2019, the retail pharmacies segment had the largest share of the Asthma Inhaler Device Market. North America had the largest market share of Asthma Inhaler in 2019.
Segmentation overview
Based on the global market, the Asthma Inhaler Device Market is segmented into-
- Type
- Mode of operation
- End-User
- Region
By Type
Based on type, the Asthma Inhaler Device Market is further segmented into-
- Metered Dose Inhalers
- Standard Pressurized Metered-Dose Inhalers
- Breath-Actuated Pressurized Metered-Dose Inhalers
- Metered-Dose Inhaler with a Spacer
- Dry Powder Inhalers
- Soft Mist Inhalers
By Mode of operation
Based on mode of operation, the Asthma Inhaler Device Market is further segmented into-
- Manually Operated Inhaler Devices
- Digitally Operated Inhaler Devices
By End-User
Based on end-user, the Asthma Inhaler Device Market is further segmented into-
- Hospitals and Clinics
- Homecare
- Others
By Region
Based on region, the Asthma Inhaler Device Market is further segmented into-
- Americas
- North America
- US
- Canada
- Latin America
- Europe
- Western Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Regional analysis
The regional Asthma Inhaler Device Market is broadly divided into the Americas, Europe, Asia-Pacific and the MEA.
Among all these regional markets, America is expected to be the most dominating region due to the increasing cases of asthma in the region. The rising demand for metered-dose inhaler and smart inhalers along with the technological advancements are providing a boost to the American Asthma Inhaler Device Market. Europe is expected to be the second largest region of the Asthma Inhaler Device Market during the forecast period. European Academy of Allergy & Clinical Immunology is making constant efforts to make people aware of the problem. The rising awareness among people and hospitals and patients adopting respiratory inhalers are driving the growth of the European market. In Asia-Pacific regional market is growing due to the rising prevalence of asthma in countries like India, china and Japan. The MEA is also expecting a steady growth because of the rising cases of asthma and demand for better treatment.
Competitive landscape
The global Asthma Inhaler Device Market is highly competitive with the presence of many prominent key players in the market. To sustain in the completion of the market, the key players are embracing various strategies such as collaboration with other players, partnership, product launch, merger and acquisition and investment in research and developments.
Major key players
- GlaxoSmithKline plc (UK)
- Koninklijke Philips NV (Netherlands)
- AstraZeneca (UK)
- Cipla Inc. (India)
- Boehringer Ingelheim International GmbH (Germany)
- Beximco Pharmaceuticals Ltd (Bangladesh)
- Merck & Co., Inc. (the US)
- Teva Pharmaceutical Industries Ltd (Israel)
- Chiesi Farmaceutici SpA (Italy)
- and Medisol Lifescience Pvt. Ltd (India).
Report Overview
The report comprises of
- Market overview
- Covid-19 impact
- Market dynamics
- Drivers
- Challenges
- Restrains
- Opportunities
- Technological analysis
- Segmentation overview
- Regional analysis
- Competitive landscape
- Recent developments
- Major key players
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size |
|
| CAGR | 6.42% (2020-2030) |
| Base Year | 2019 |
| Forecast Period | 2020-2030 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Mode of Operation, End User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | GlaxoSmithKline plc (UK), Koninklijke Philips NV (Netherlands), AstraZeneca (UK), Cipla Inc. (India), Boehringer Ingelheim International GmbH (Germany), Beximco Pharmaceuticals Ltd (Bangladesh), Merck & Co., Inc. (the US), Teva Pharmaceutical Industries Ltd (Israel), Chiesi Farmaceutici SpA (Italy), and Medisol Lifescience Pvt. Ltd (India). |
| Key Market Opportunities | New product launches and R&D Amongst major key Players |
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
Asthma Inhaler Device Market is predicted to touch USD 19, 677.54 million by 2025.
Asthma Inhaler Device Market is projected to grow at a 6.42% CAGR between 2016-2025.
Americas are projected to have a major share in the Asthma Inhaler Device Market.
Key competitors in the Asthma Inhaler Device Market include Medisol Lifescience Pvt. Ltd (India), Chiesi Farmaceutici SpA (Italy), Teva Pharmaceutical Industries Ltd (Israel), Merck & Co., Inc. (the US), Beximco Pharmaceuticals Ltd (Bangladesh), Boehringer Ingelheim International GmbH (Germany), Cipla Inc. (India), AstraZeneca (UK), Koninklijke Philips NV (Netherlands), and GlaxoSmithKline plc (UK).
Specific strategies adopted by key players to create a footprint in the Asthma Inhaler Device Market include acquisition, expansion, collaborations, product launch and approval.
